) and i ntegri n\x=req-\ independent (CD44) pathways, and revealed marked differences when comparing GO-OECs and normal OECs. In conclusion, the availability of OECs from affected retroorbital tissue of patients with GO provides a valuable tool for studying further the mechanisms responsible for orbit-specific lymphocyte recruitment in GO.
expressed intercellular adhesion molecule 1 (ICAM-1) and CD44 immunoreactivity but no immunoreactivity for endothelial leukocyte adhesion molecule I (ELAM-1) and vascular cell adhesion molecule I (VCAM-1) was detected. Exposure of GO-OEC and normal OEC monolayers to interferon \g=g\, interleukin 1 \ g=a\ and tumor necrosis factor \g=a\ resulted in marked up-regulation of immunoreactivity for ICAM-1 and in induction of ELAM-1 and VCAM-1. Blocking experiments using monoclonal antibodies directed against various adhesion molecules demonstrated that interactions between matched activated T lymphocytes and OECs were mediated by integrin-dependent ICAM-1/leukocyte function-associated antigen 1 (LFA-1): VCAM-1/very late antigen 4 (VLA-4)) and i ntegri n\x=req-\ independent (CD44) pathways, and revealed marked differences when comparing GO-OECs and normal OECs. In conclusion, the availability of OECs from affected retroorbital tissue of patients with GO provides a valuable tool for studying further the mechanisms responsible for orbit-specific lymphocyte recruitment in GO. Armin E Heufelder, Molecular Thyroid Research Unit, Medizinische Klinik, Klinikum Innenstadt, Ziemssenstrasse 1, 80336 M\l=u"\nchen, Germany
Graves' ophthalmopathy (GO), an inflammatory condi¬ tion affecting the retroorbital space, represents the most common extrathyroidal manifestation of Graves' disease (1, 2) . The histological hallmarks of GO include infiltration of the orbital tissues by inflammatory cells, proliferation of the orbital and perimysial connective tissue and the accumulation of hydrophilic glycosaminoglycans (GAGs) (3) (4) (5) . These features are responsible for the prominent alterations of the retroorbital tissue compartment and play a central role in the evolution of GO, leading to the clinical manifestations of proptosis, diplopia, periorbital swelling and inflamma¬ tion (2) . Various (6) . Cytokine effects of potential relevance to the orbital disease process in GO include, among others, the induction of MHC class II molecules, heat shock proteins and adhesion molecules in retroorbital fibroblasts (2, 3, (7) (8) (9) . These cells are likely to be both target cells and effector cells in the ongoing immune process in GO (1, (10) (11) (12) . Recent (12, 13) . In support of this concept, lymphocytes derived from the retroorbital tissue of patients with GO have been found to recognize specifically autologous retroorbital and, to a lesser degree, autologous skin fibroblasts, suggesting that retroorbital fibroblasts represent a major orbital target for cells (12 (Fig. 1B-D (Fig. 6) . Taken (Fig. 7) . Further, major differences in T-cell adhesion to untreated or cytokineactivated GO (20) . Engagement of other adhesion receptors may activate CD44 on lympho¬ cytes, thereby enhancing their affinity for hyaluronic acid (23, 24) . T-cell adhesion is accompanied by the clustering of CD44 molecules on the surface of lymphocytes oriented toward the endothelium (22, 25 (7, 9) . This suggests that lymphocytes expressing LFA-1 and VLA-4 may interact with retroorbital fibroblasts via ICAM-1 and VCAM-1.
Both ICAM-1 and VCAM-1 are induced by proinflammatory cytokines, namely IFN-7, TNF-a and IL-1, on retroorbital fibroblasts (9) and, as demonstrated here, on orbital endothelial cells. Immunoreactivity for these cytokines has been detected in situ within the retro¬ orbital tissues in GO (6) . In (27) 
